BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18061591)

  • 1. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.
    Ebert AD; Beres AJ; Barber AE; Svendsen CN
    Exp Neurol; 2008 Jan; 209(1):213-23. PubMed ID: 18061591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
    Ericson C; Georgievska B; Lundberg C
    Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
    Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
    J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GDNF pretreatment on function and survival of transplanted fetal ventral mesencephalic cells in the 6-OHDA rat model of Parkinson's disease.
    Andereggen L; Meyer M; Guzman R; Ducray AD; Widmer HR
    Brain Res; 2009 Jun; 1276():39-49. PubMed ID: 19389387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.
    Piltonen M; Bespalov MM; Ervasti D; Matilainen T; Sidorova YA; Rauvala H; Saarma M; Männistö PT
    Exp Neurol; 2009 Oct; 219(2):499-506. PubMed ID: 19615368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA; Su C
    Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease.
    Yasuhara T; Shingo T; Kobayashi K; Takeuchi A; Yano A; Muraoka K; Matsui T; Miyoshi Y; Hamada H; Date I
    Eur J Neurosci; 2004 Mar; 19(6):1494-504. PubMed ID: 15066146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.
    Behrstock S; Ebert A; McHugh J; Vosberg S; Moore J; Schneider B; Capowski E; Hei D; Kordower J; Aebischer P; Svendsen CN
    Gene Ther; 2006 Mar; 13(5):379-88. PubMed ID: 16355116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys.
    Emborg ME; Ebert AD; Moirano J; Peng S; Suzuki M; Capowski E; Joers V; Roitberg BZ; Aebischer P; Svendsen CN
    Cell Transplant; 2008; 17(4):383-95. PubMed ID: 18522241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease.
    Mandel RJ; Snyder RO; Leff SE
    Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
    Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
    Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson's disease.
    Carvey PM; Ling ZD; Sortwell CE; Pitzer MR; McGuire SO; Storch A; Collier TJ
    Exp Neurol; 2001 Sep; 171(1):98-108. PubMed ID: 11520124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease.
    Svendsen CN; Caldwell MA; Shen J; ter Borg MG; Rosser AE; Tyers P; Karmiol S; Dunnett SB
    Exp Neurol; 1997 Nov; 148(1):135-46. PubMed ID: 9398456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
    Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
    Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
    Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
    Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
    Baker KA; Hong M; Sadi D; Mendez I
    Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.